CCAAT/enhancer binding proteins in normal mammary development and breast cancer

Research output: Contribution to journalReview article

Abstract

CCAAT/enhancer binding proteins (C/EBPs) are a family of leucine zipper, transcription factors that bind to DNA as homodimers and heterodimers. They regulate cellular proliferation, differentiation and apoptosis in the mammary gland. Multiple protein isoforms, including truncated, dominant negatives, are generated by translation of the C/EBPβ transcript or via proteolytic cleavage of the full-length C/EBPβ protein. Gene deletion of individual C/EBP family members has demonstrated an essential role for C/EBPβ in normal mammary development, while transgenic and overexpression studies provide evidence that the dominant-negative C/EBPβ-liver-enriched inhibitory protein isoform induces proliferation in mammary epithelial cells. Mounting evidence suggests that alterations in the ratio of the C/EBPβ-liver-enriched inhibitory protein isoform and the C/EBPβ-liver-enriched activating protein isoform may play a role in the development of breast cancer. This review will consequently focus on C/EBP actions in normal mammary development and on the emerging data that supports a role in breast cancer.

Original languageEnglish (US)
Pages (from-to)113-121
Number of pages9
JournalBreast Cancer Research
Volume4
Issue number3
DOIs
StatePublished - May 27 2002

Keywords

  • Breast cancer
  • CCAAT/enhancer binding proteins
  • Dominant-negative transcription factor
  • Mammary development
  • Translational regulation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'CCAAT/enhancer binding proteins in normal mammary development and breast cancer'. Together they form a unique fingerprint.

  • Cite this